These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10794805)

  • 1. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.
    Agarwala SS; Kirkwood JM
    Oncologist; 2000; 5(2):144-51. PubMed ID: 10794805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide for Treating Malignant Melanoma.
    Li RH; Hou XY; Yang CS; Liu WL; Tang JQ; Liu YQ; Jiang G
    J Coll Physicians Surg Pak; 2015 Sep; 25(9):680-8. PubMed ID: 26374366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group.
    Margolin K; Atkins B; Thompson A; Ernstoff S; Weber J; Flaherty L; Clark I; Weiss G; Sosman J; II Smith W; Dutcher P; Gollob J; Longmate J; Johnson D
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):214-8. PubMed ID: 11935312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide: a novel oral alkylating agent.
    Danson SJ; Middleton MR
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide in malignant gliomas: current use and future targets.
    Villano JL; Seery TE; Bressler LR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
    Bael TE; Peterson BL; Gollob JA
    Melanoma Res; 2008 Apr; 18(2):147-51. PubMed ID: 18337652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].
    Conill C; Fernández-Ibiza J; Malvehy J; Puig S; Sánchez M; Castel T
    Med Clin (Barc); 2004 Mar; 122(11):413-5. PubMed ID: 15066248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 9. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of temozolomide in pediatric brain tumors.
    Barone G; Maurizi P; Tamburrini G; Riccardi R
    Childs Nerv Syst; 2006 Jul; 22(7):652-61. PubMed ID: 16565851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
    Tentori L; Leonetti C; Scarsella M; D'Amati G; Vergati M; Portarena I; Xu W; Kalish V; Zupi G; Zhang J; Graziani G
    Clin Cancer Res; 2003 Nov; 9(14):5370-9. PubMed ID: 14614022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of action.
    Bei R; Marzocchella L; Turriziani M
    Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):172-87. PubMed ID: 20594183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma.
    Paul MJ; Summers Y; Calvert AH; Rustin G; Brampton MH; Thatcher N; Middleton MR
    Melanoma Res; 2002 Apr; 12(2):175-8. PubMed ID: 11930115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
    Gogas H; Polyzos A; Stavrinidis I; Frangia K; Tsoutsos D; Panagiotou P; Markopoulos C; Papadopoulos O; Pectasides D; Mantzourani M; Middleton M; Vaiopoulos G; Fountzilas G
    Ann Oncol; 2006 Dec; 17(12):1835-41. PubMed ID: 16980601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide as prophylaxis for melanoma brain metastases.
    Conill C; González-Cao M; Jorcano S; Puig S; Malvehy J; Martí R; Castel T
    Melanoma Res; 2004 Feb; 14(1):73-4. PubMed ID: 15091198
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete response of multiple melanoma brain metastases after treatment with temozolomide.
    Dvorak J; Melichar B; Zizka J; Hadzi-Nikolov D; Petera J
    Onkologie; 2004 Apr; 27(2):171-4. PubMed ID: 15138351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.